Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AMPH

Amphastar

$21.63

0.95 (4.59%)

16:29
11/09/18
11/09
16:29
11/09/18
16:29
Syndicate
Breaking Syndicate news story on Amphastar »

Amphastar files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

Thursday
AMPH

Amphastar

$20.68

1.44 (7.48%)

16:47
11/08/18
11/08
16:47
11/08/18
16:47
Earnings
Amphastar reports Q3 adj. EPS 12c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

AMPH

Amphastar

$20.25

1.01 (5.25%)

09:53
11/08/18
11/08
09:53
11/08/18
09:53
Recommendations
Amphastar analyst commentary at Wells Fargo »

Amphastar inhaler…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

AMPH

Amphastar

$19.70

0.46 (2.39%)

09:47
11/08/18
11/08
09:47
11/08/18
09:47
Hot Stocks
Amphastar announces FDA approves reintroduction of Primatene MIST »

Amphastar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

Over a quarter ago
AMPH

Amphastar

$17.21

-0.74 (-4.12%)

10:41
08/09/18
08/09
10:41
08/09/18
10:41
Recommendations
Amphastar analyst commentary at Wells Fargo »

Amphastar shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPH

Amphastar

$17.95

0.16 (0.90%)

16:44
08/08/18
08/08
16:44
08/08/18
16:44
Earnings
Amphastar reports Q2 EPS 3c, consensus 7c »

Reports Q2 revenue $71M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

AMPH

Amphastar

$16.64

0.28 (1.71%)

05:22
07/20/18
07/20
05:22
07/20/18
05:22
Recommendations
Amphastar analyst commentary at Wells Fargo »

Wells Fargo positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPH

Amphastar

$16.35

0.01 (0.06%)

06:25
07/09/18
07/09
06:25
07/09/18
06:25
Hot Stocks
Amphastar announces expansion of Amphastar Nanjing Pharmaceuticals »

Amphastar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPH

Amphastar

$17.04

0.21 (1.25%)

, VRX

Ticker changed BHC

$24.35

0.81 (3.44%)

12:43
06/19/18
06/19
12:43
06/19/18
12:43
Recommendations
Amphastar, Ticker changed BHC analyst commentary at Wells Fargo »

Amphastar generic Isuprel…

AMPH

Amphastar

$17.04

0.21 (1.25%)

VRX

Ticker changed BHC

$24.35

0.81 (3.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

AMPH

Amphastar

$16.83

-0.03 (-0.18%)

, VRX

Ticker changed BHC

$23.54

-3.32 (-12.36%)

06:03
06/19/18
06/19
06:03
06/19/18
06:03
Hot Stocks
Amphastar granted approval by FDA for Isoproterenol Hydrochloride Injection »

Amphastar Pharmaceuticals…

AMPH

Amphastar

$16.83

-0.03 (-0.18%)

VRX

Ticker changed BHC

$23.54

-3.32 (-12.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.